Z. Nad and F. , The potential advantages of a modern antihypertensive therapy in the eider/y, J Cardiovasc Pharmacol, vol.353, pp.19-23, 2000.

A. , R. Vol, S. Pannier, B. Brisac, A. Tichet et al., A High blood pressure and associated cardiovascular risk factors in France, J Hypertens, vol.19, pp.1727-1759, 2001.

A. and R. Mapa, Arch Mal Coeur Vaiss Prat, p.19, 2001.

H. and P. Gavras, Issues in hypertension: drug tolerability and special populations, American Journal of Hypertension, vol.14, issue.11, pp.231-237, 2001.
DOI : 10.1016/S0895-7061(01)02132-X

URL : https://academic.oup.com/ajh/article-pdf/14/4S/231S/416890/14_4S_231S.pdf

A. The, C. Officers, . For, . Allhat-collaborative-research, and . Group, Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic.The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), pp.2981-97, 2002.

S. , A. L-'étude, and H. , démonstration de la protection cardiovasculaire du ramipril, un inhibiteur de l'enzyme de conversion de l'angiotensine, Rev Med Liege, vol.54, issue.10, pp.835-841, 1999.

. Progress-collaborative and . Group, Randomized trial of a perindopril-based blood-pressure-Iowering regimen among 6105 individuals with previous stroke or transient ischaemic attack, Lancet, vol.358, pp.1033-1074, 2001.

M. and M. Md, Compliance in hypertension: Why don't patients take their piIls? JAMC 1999, pp.64-69

H. , L. Zanchetti, A. , C. , and S. , Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group, Lancet, vol.351, pp.1755-62, 1998.

S. , E. Anderson, J. Maloney, M. Jay, S. Fagan et al., Factors associated with noncompliance of patients taking antihypertensive medications, Hosp Pharm, vol.30, issue.3, pp.201-204, 1995.

J. M. Malllon and D. Schmitt, Patient compliance in the treatment of arterial hypertension, Journal of Hypertension, vol.19, issue.12, pp.2281-2284, 2001.
DOI : 10.1097/00004872-200112000-00024

B. , M. Santschi, V. Fallab-stubi, C. Chiolero, A. Schneider et al., Hypertension -Observance thérapeutique: de l'impression du médecin à la télémétrie, Rev med Suisse romande, vol.122, pp.467-70, 2002.

W. , B. Burnier, M. Brunner, and H. , How to improve adherence with prescribed treatment in hypertensive patients?, J Cardiovasc Pharmacol, vol.35, pp.23-29, 2000.

M. , J. Magalhaes, E. De-oliveira, and A. , The adverse effects of antihypertensive therapy : the perception of patients. Rev Port Cardial, pp.123-153, 1999.

D. , R. Weisser, B. Mengden, T. Vetter, and H. , Changes in antihypertensive therapy -the role of adverse effects and compliance, Blood Press, vol.7, pp.313-318, 1998.

G. H. Williams, Assessing patient wellness: new perspectives on quality of life and compliance, American Journal of Hypertension, vol.11, issue.3, pp.186-91, 1998.
DOI : 10.1016/S0895-7061(98)00196-4

A. , R. Zanchetti, and A. , Guidelines for the use of self blood pressure monitoring: a summary report of the first international consensus conference

S. Svensson, Reasons for adherence with antihypertensive medication, International Journal of Cardiology, vol.76, issue.2-3, pp.157-63, 2000.
DOI : 10.1016/S0167-5273(00)00374-0

G. , X. Hanon, O. Anagnostopoulos, K. Ciupek, C. Mourao et al., Evaluation de l'observance du traitement antihypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé, Presse Med, vol.30, pp.1044-1052, 2001.

L. Blue, E. Lang, and . Mcmurray, Randomised controlled trial of specialist nurse intervention in heart failure, BMJ, vol.323, issue.7315, pp.715-723, 2001.
DOI : 10.1136/bmj.323.7315.715

B. , E. Gasche, A. Zimmerli, L. Martina, B. Gyr et al., Risk factor control and perceptions of risk factors in patients with coronary heart disease, pp.17-22, 1997.

K. , K. I. Ahlner, J. Oahlof, B. Gill, H. Heoner et al., Perceived symptoms amongst hypertensive patients in routine clinical practice -a population-based study, J Intern Med, vol.244, pp.325-357, 1998.

J. , E. Kumpusalo, E. Enluno, H. Takala, and J. , Patients' perceived problems with hypertension and attitudes towards medical treatment, J Hum Hypertens, vol.15, issue.11, pp.755-61, 2001.

P. , C. Lin, P. Aro, J. Mcclure, M. Svetkey et al., The effects of dietary patterns on quality of life : a substudy of the Oietary Approaches to Stop Hypertension trial (OASH), J Am Diet Assac, vol.99, issue.8, 1999.

O. Group, Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (OASH). N EnglJ Med2001, pp.3-10

R. Tone-collaborative and . Group, Sodium Reduction and Weight loss in the treatment of Hypertension in older Persons. A randomized Controlled trial of Non-pharmacologic interventions in the Elderly (TONE), JAMA, vol.279, pp.839-846, 1998.

S. , M. Patsi, O. Fasoi, and G. , The Influence of the Hypertensive Patient's Education in Compliance with their Medication, Public Health Nursing, vol.18, issue.6, pp.436-478, 2001.

S. Oui, quelle est votre tension actuelle? (ex: 13/08) 2

. Actuellement, suivez-vous un traitement contre l'hypertension artérielle? 1 . Oui 0 2

. Si-oui, lequel: 6. depuis combien de temps : 1. 0 < 6 mois 3

.. Au-total, combien de comprimés, prenez-vous chaque jour?